109 related articles for article (PubMed ID: 30605956)
1. [The 467th case: proteinuria, periungual fibromas, and facial steatadenomas].
Chen G; Dong QR; Li MX; Li XM
Zhonghua Nei Ke Za Zhi; 2019 Jan; 58(1):74-77. PubMed ID: 30605956
[TBL] [Abstract][Full Text] [Related]
2. Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2.
Bissler JJ; Budde K; Sauter M; Franz DN; Zonnenberg BA; Frost MD; Belousova E; Berkowitz N; Ridolfi A; Christopher Kingswood J
Nephrol Dial Transplant; 2019 Jun; 34(6):1000-1008. PubMed ID: 30053159
[TBL] [Abstract][Full Text] [Related]
3. Tuberous sclerosis with two unusual findings: cutaneous rhabdomyoma and chronic myelogenous leukaemia.
Bardawil T; El Jamal L; Abbas O; Kurban M
Clin Exp Dermatol; 2020 Aug; 45(6):799-801. PubMed ID: 32097503
[No Abstract] [Full Text] [Related]
4. Advanced sporadic renal epithelioid angiomyolipoma: case report of an extraordinary response to sirolimus linked to TSC2 mutation.
Espinosa M; Roldán-Romero JM; Duran I; de Álava E; Apellaniz-Ruiz M; Cascón A; Garrigos C; Robledo M; Rodriguez-Antona C
BMC Cancer; 2018 May; 18(1):561. PubMed ID: 29764404
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin inhibitors in a patient with polycystic kidney disease-1-tuberous sclerosis-2 contiguous gene syndrome.
Anandh U; Chandrasekar G; Agarwal V
Saudi J Kidney Dis Transpl; 2018; 29(6):1475-1479. PubMed ID: 30588981
[TBL] [Abstract][Full Text] [Related]
6. Malignancy of renal angiomyolipoma from tuberous sclerosis complex with TSC2 mutation.
Huang YJ; Jiang ZP; Chen YP; Wu JQ; Huang JL; Chen YQ; Liang MJ
Chin Med J (Engl); 2019 Jan; 132(1):103-105. PubMed ID: 30628968
[No Abstract] [Full Text] [Related]
7. Liver Angiomyolipomas in Tuberous Sclerosis Complex-Their Incidence and Course.
Jóźwiak S; Sadowski K; Borkowska J; Domańska-Pakieła D; Chmielewski D; Jurkiewicz E; Jaworski M; Urbańska M; Ogrodnik M; Słowińska M; Kotulska K
Pediatr Neurol; 2018 Jan; 78():20-26. PubMed ID: 29249553
[TBL] [Abstract][Full Text] [Related]
8. Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.
Wienecke R; Fackler I; Linsenmaier U; Mayer K; Licht T; Kretzler M
Am J Kidney Dis; 2006 Sep; 48(3):e27-9. PubMed ID: 16931204
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus and tuberous sclerosis-associated renal angiomyolipomas.
Krischock L; Beach R; Taylor J
Arch Dis Child; 2010 May; 95(5):391-2. PubMed ID: 20457704
[TBL] [Abstract][Full Text] [Related]
10. Tuberous sclerosis complex case series with novel duplication mutations of TSC2.
Lee JM; Kim JH; Choi SH
Clin Neurol Neurosurg; 2019 Nov; 186():105498. PubMed ID: 31542468
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of sirolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: a systematic review.
Peng ZF; Yang L; Wang TT; Han P; Liu ZH; Wei Q
J Urol; 2014 Nov; 192(5):1424-30. PubMed ID: 24813310
[TBL] [Abstract][Full Text] [Related]
12. Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex.
Peces R; Peces C; Cuesta-López E; Pérez-Dueñas V; Vega-Cabrera C; Azorín S; Selgas R
Nephrol Dial Transplant; 2010 Nov; 25(11):3787-91. PubMed ID: 20663789
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis complex: tumors and tumorigenesis.
Borkowska J; Schwartz RA; Kotulska K; Jozwiak S
Int J Dermatol; 2011 Jan; 50(1):13-20. PubMed ID: 21182496
[TBL] [Abstract][Full Text] [Related]
14. Isolated and unilateral facial angiofibromas revealing a type 1 segmental postzygotic mosaicism of tuberous sclerosis complex with c.4949_4982del TSC2 mutation.
Bessis D; Malinge MC; Girard C
Br J Dermatol; 2018 Jan; 178(1):e53-e54. PubMed ID: 29315486
[No Abstract] [Full Text] [Related]
15. [Terminal kidney insufficiency in tuberous sclerosis].
Krieter DH; Müller GA
Dtsch Med Wochenschr; 1995 May; 120(20):718-22. PubMed ID: 7758411
[TBL] [Abstract][Full Text] [Related]
16. [Renal manifestations in tuberous sclerosis].
Ben Hamida F; Gorsane I; Gharbi C; Kaaroud H; Barbouch S; Smaoui W; Helal I; Beji S; Goucha R; Hedri H; Ben Moussa F; Ben Abdallah T; Ben Maiz H; Kheder A
Rev Med Interne; 2006 Nov; 27(11):836-42. PubMed ID: 17007967
[TBL] [Abstract][Full Text] [Related]
17. [Tuberous sclerosis].
Metsähonkala L; Valanne L; Anttonen AK
Duodecim; 2013; 129(17):1779-87. PubMed ID: 24159711
[TBL] [Abstract][Full Text] [Related]
18. [Steroid-responsive nephrotic syndrome in IgA nephropathy].
García Camín RM; Cabezas A; Calero F; Ballarín JA
Nefrologia; 2004; 24 Suppl 3():68-71. PubMed ID: 15219073
[TBL] [Abstract][Full Text] [Related]
19. Angiofibromas with multiple epidermoid cysts in tuberous sclerosis: new mutation or post-traumatic?
Zheng LQ; Huang Y; Han XC
J Cutan Pathol; 2013 May; 40(5):509-12. PubMed ID: 23418925
[TBL] [Abstract][Full Text] [Related]
20. Tuberous sclerosis complex with end-stage renal failure.
Neumann HP; Brüggen V; Berger DP; Herbst E; Blum U; Morgenroth A; Schollmeyer P; Wetterauer U
Nephrol Dial Transplant; 1995; 10(3):349-53. PubMed ID: 7792029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
